Medtech firm gets new start in Austin

Acessa Health ac­quired non­in­va­sive treat­ment for uter­ine fi­broids.

Austin American-Statesman - - BUSINESS - By Lori Hawkins lhawkins@states­man.com Acessa

It’s been a whirl­wind few months for med­i­cal de­vice maker Acessa Health.

In June, the com­pany an­nounced it had ac­quired a non­in­va­sive treat­ment for uter­ine fi­broids from a Cal­i­for­nia med­i­cal de­vice com­pany.

At the same time, the com­pany said it had se­cured $30 mil­lion in Se­ries A fi­nanc­ing to ex­pand its prod­uct port­fo­lio, de­velop new tech­nol­ogy, and ex­pand sales and mar­ket­ing.

Mean­while, Acessa moved from North­ern Cal­i­for­nia to Austin, which now serves as its global head­quar­ters.

“Austin is the right place for us,” said Kim Bridges Ro­driguez, CEO of Acessa Health. “A lot of small medtech com­pa­nies are start­ing to emerge, and I be­lieve this is one of the next big medtech op­por­tu­nity spots. You have it in North­ern Cal­i­for­nia, in Min­nesota; it’s start­ing to emerge in Colorado. I be­lieve Austin will be on that list.”

Acessa (pro­nounced uh-SESS-a) pur­chased the FDA-ap­proved de­vice from Halt Med­i­cal, a Brent-

Ro­driguez: “Austin is the right place for us.”

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.